Ian H. Plenderleith
About
In The Last Decade
Ian H. Plenderleith
13 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Cancer Research 1.1k
- Surgery 594
- Pathology and Forensic Medicine 572
- Oncology 562
- Pulmonary and Respiratory Medicine 201
Countries citing papers authored by Ian H. Plenderleith
This map shows the geographic impact of Ian H. Plenderleith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian H. Plenderleith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian H. Plenderleith more than expected).
Fields of papers citing papers by Ian H. Plenderleith
This network shows the impact of papers produced by Ian H. Plenderleith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian H. Plenderleith. The network helps show where Ian H. Plenderleith may publish in the future.
Co-authorship network of co-authors of Ian H. Plenderleith
This figure shows the co-authorship network connecting the top 25 collaborators of Ian H. Plenderleith. A scholar is included among the top collaborators of Ian H. Plenderleith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian H. Plenderleith. Ian H. Plenderleith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer breakdown → | 1280 |
| 2 | 54 | |
| 3 | 11 | |
| 4 | 64 | |
| 5 | 7 | |
| 6 | Treating the treatment: toxicity of cancer chemotherapy. | 37 |
| 7 | 1 | |
| 8 | Bacille Calmette-Guérin as maintenance therapy for non-Hodgkin's lymphoma. | 3 |
| 9 | Observations in immunotherapy of lymphoma and melanoma patients. | 11 |
| 10 | Hairy cell leukemia. | 42 |
| 11 | 66 | |
| 12 | 13 | |
| 13 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.